Bunkerhill ECG-EF vs Tempus ECG-AF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 75/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These two tools are adjacent rather than direct competitors, as they leverage AI to analyze 12-lead ECGs for distinct cardiac conditions. Bunkerhill ECG-EF focuses on identifying reduced left ventricular ejection fraction to aid in early heart failure detection. In contrast, Tempus ECG-AF predicts the risk of developing atrial fibrillation in older patients, making the choice dependent on the specific cardiac risk assessment required.
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if your primary objective is to non-invasively screen for reduced left ventricular ejection fraction (LVEF ≤ 40%) using routine 12-lead ECGs. This tool is ideal for aiding in the early identification of patients at risk for heart failure, supporting proactive clinical management.
View Bunkerhill ECG-EF →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if you need to identify patients aged 65 or older who are at an increased risk of developing new-onset atrial fibrillation or flutter within the next 12 months. This algorithm is best suited for targeted screening in geriatric populations to facilitate earlier AF detection and follow-up.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact sales for pricing details. | Contact vendor |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | Tempus ECG-AF |
|---|---|---|
| Name | Bunkerhill ECG-EF | Tempus ECG-AF |
| Primary Detection Target | Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) | Increased risk of developing Atrial Fibrillation/Flutter (AF) within 12 months |
| Company | BunkerHill Health | Tempus AI, Inc. |
| Target Patient Population | Patients at risk for heart failure | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
| Key Input Data | Routine 12-lead electrocardiograms (ECGs) | 12-lead ECG recordings |
| Integration/Compatibility | Integrates with Electronic Medical Records (EMR) or ECG Management Systems (EMS) | Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Tempus ECG-AF.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Bunkerhill ECG-EF detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. Tempus ECG-AF analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Bunkerhill ECG-EF is intended for adults at risk for, but not already diagnosed with low LVEF, using routine 12-lead ECGs for early heart failure risk identification. Tempus ECG-AF is specifically for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs) and clinical archives. Tempus ECG-AF is a software solution integrated into healthcare facility systems with advanced cardiology algorithms.
Tempus ECG-AF has CMS reimbursement available, with CPT codes 0764T and 0765T assigned to APC 5734, at a Medicare rate of $128.90, effective January 1, 2025. For Bunkerhill ECG-EF, pricing information requires contacting the vendor.
Bunkerhill ECG-EF analyzes routine 12-lead ECG data. Tempus ECG-AF is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.
Bunkerhill ECG-EF aids in the early identification of patients at risk for heart failure. Tempus ECG-AF supports earlier identification and follow-up for patients at increased risk of developing atrial fibrillation/flutter within 12 months.
Bunkerhill ECG-EF is part of the Carebricks platform for clinical reasoning and action. Tempus ECG-AF is a software solution that integrates into healthcare facility systems.
More Comparisons
More matchups featuring Bunkerhill ECG-EF or Tempus ECG-AF
Backers
Who funded each tool's parent company.